Shrinking a Qidni

Morteza Ahmadi, CEO of Quidni labs, aims to design a small blood purification device that will offer longer treatment times and ultimately replace dialysis in clinics—at 40% less cost. With grants from programs including the Canadian Space Agency, the vision of Qidni is to “surpass current technology to become the new standard of treatment and help millions of patients on dialysis live a normal life.”

Read the full article » | Posted 03-16-2020

Related Articles

• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
• Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
• Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026